Overcoming Drug Resistance in Gynecologic Cancers
eBook - ePub

Overcoming Drug Resistance in Gynecologic Cancers

,
  1. 388 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Overcoming Drug Resistance in Gynecologic Cancers

,
Book details
Table of contents
Citations

About This Book

Overcoming Drug Resistance in Gynecologic Cancers provides up-to-date information related to important gynecologic cancers and focuses on mechanisms of drug resistance, genetics, signaling, immunology, health disparities, nanotechnology, economic considerations and financial impacts. The book covers not only drug resistance but also important means to reverse resistance both in the laboratory and clinic. The book discusses topics such as lifestyle, nutrition and risk of gynecologic cancers, the financial impact of drug resistance, chemosensitizing agents and targeted therapies in cervical, endometrial and ovarian cancer, immunotherapy to overcome drug resistance, and genetic polymorphisms in gynecologic cancers.

Additionally, it discusses ethnic and racial health disparity perspectives and future developments in chemosensitizing activities to reverse drug resistance in gynecologic cancers. It is a valuable resource for cancer researchers, oncologists, clinicians and other biomedical field members who are interested in new approaches to improve chemotherapy outcome in patients with gynecologic cancers.

  • Provides a comprehensive resource with all the details needed for readers to understand and follow information
  • Encompasses schematics, diagrams and flow charts in all chapters to help readers easily follow critical information
  • Presents tables and figures especially developed to summarize the information with appropriate statistical rigor and to show details of clinical specimens such as pathological, radiological characteristics, and/or laboratory biomarkers

Frequently asked questions

Simply head over to the account section in settings and click on “Cancel Subscription” - it’s as simple as that. After you cancel, your membership will stay active for the remainder of the time you’ve paid for. Learn more here.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlego’s features. The only differences are the price and subscription period: With the annual plan you’ll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access Overcoming Drug Resistance in Gynecologic Cancers by in PDF and/or ePUB format, as well as other popular books in Ciencias biológicas & Biología. We have over one million books available in our catalogue for you to explore.

Information

Publisher
Academic Press
Year
2021
ISBN
9780128243008
Topic
Ciencias biológicas
Subtopic
Biología

Table of contents

  1. Cover image
  2. Title page
  3. Table of Contents
  4. Copyright
  5. Cover Image Insert
  6. Aims and Scope for Series “Cancer Sensitizing Agents for Chemotherapy”
  7. About the Series Editor
  8. Aims and Scope of the Volume
  9. About the Volume Editors
  10. Preface
  11. Contributors
  12. Chapter 1: Introduction to gynecologic cancers: Emphasis on pathogenesis, incidence, and diagnosis
  13. Chapter 2: Lifestyle, nutrition, and risk of gynecologic cancers
  14. Chapter 3: Drug resistance in gynecologic cancers: Findings and underlying mechanisms
  15. Chapter 4: Mechanisms of chemoresistance and approaches to overcome its impact in gynecologic cancers
  16. Chapter 5: Current treatment modalities in major gynecologic cancers: Emphasis on response rates
  17. Chapter 6: Drug resistance in gynecologic cancers: Emphasis on noncoding RNAs and drug efflux mechanisms
  18. Chapter 7: Genetic polymorphisms in gynecologic cancers
  19. Chapter 8: Overcoming drug resistance in cervical cancer: Chemosensitizing agents and targeted therapies
  20. Chapter 9: Immune response, inflammation pathway gene polymorphisms, and the risk of cervical cancer
  21. Chapter 10: Overcoming chemotherapy resistance in endometrial cancer
  22. Chapter 11: Chemoresistance in uterine cancer: Mechanisms of resistance and current therapies
  23. Chapter 12: Ovarian cancer: Targeted therapies and mechanisms of resistance
  24. Chapter 13: Overcoming drug resistance in ovarian cancer: Chemo-sensitizing agents, targeted therapies
  25. Chapter 14: Resistance to chemotherapy among ethnic and racial groups: Health disparities perspective in gynecologic cancers
  26. Chapter 15: Future perspectives and new directions in chemosensitizing activities to reverse drug resistance in gynecologic cancers: Emphasis on challenges and opportunities
  27. Index